Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
about
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human geneticsInterferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression.Intestinal permeability defects: is it time to treat?Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancerIntestinal permeability regulation by tight junction: implication on inflammatory bowel diseasesClinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent updateIntestinal epithelium in inflammatory bowel diseaseMucosal injuries due to ribosome-inactivating stress and the compensatory responses of the intestinal epithelial barrierDifferential effects of TNF (TNFSF2) and IFN-γ on intestinal epithelial cell morphogenesis and barrier function in three-dimensional cultureCrosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal HyperpermeabilityIntestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky GutIntestinal barrier function: molecular regulation and disease pathogenesisProtection of Gastrointestinal Mucosa from Acute Heavy Alcohol Consumption: The Effect of Berberine and Its Correlation with TLR2, 4/IL1β-TNFα SignalingProinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell lineIncreased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese miceOccludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux.Microtubules are required for efficient epithelial tight junction homeostasis and restoration.Parallels between pathogens and gluten peptides in celiac sprueRegulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.Tight junctions in salivary epitheliumRole of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity.Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo.Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel diseaseAnti-inflammatory and Intestinal Barrier-protective Activities of Commensal Lactobacilli and Bifidobacteria in Thoroughbreds: Role of Probiotics in Diarrhea Prevention in Neonatal Thoroughbreds.Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents.Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivoGastrointestinal mucosal barrier function and diseases.The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury Model.Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice.Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update.Intestinal fatty acid binding protein as a marker for intra-abdominal pressure-related complications in patients admitted to the intensive care unit; study protocol for a prospective cohort study (I-Fabulous study).IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunctionMolecular basis of epithelial barrier regulation: from basic mechanisms to clinical application.Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruptionTumor necrosis factor alpha is a key mediator of gut inflammation seen in amebic colitis in human intestine in the SCID mouse-human intestinal xenograft model of disease.High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids.Increased gut permeability in Crohn's disease: is TNF the link?
P2860
Q21131205-0B34E922-EC34-4DF2-A300-72C65E36FE94Q24536188-DAF7698A-54CD-4809-A7A1-D241AE484BD1Q24629228-D6CDCFEB-F9AC-4502-B522-64C43ED0DF98Q26752750-E15BAF2A-7C28-47E6-9091-9D27A0777E69Q26859272-E85AEDFF-AC11-4D59-A3E8-6ABC8B1E02A2Q26994776-1E9B8516-7B87-44BC-9609-E96E6590966BQ27022092-65F9CB40-2CF8-43DD-A69A-5D967F1DBBC9Q27027390-848A6E50-8017-4B65-B517-B14127C4B13BQ27329003-93DCEA7C-8767-43E8-A2BD-19BAB224ECE8Q28079482-2E739ECC-6106-43D0-B067-213FFD4266FCQ28081848-312E0EEB-7A31-4F04-BBAF-40C8AF2B63F0Q28250081-DFB5083A-CA59-4774-AF73-392554693F04Q28384697-A192CB32-C1A0-4930-9348-FD8DC64A2334Q28568696-D6545440-514D-4B1A-8996-04150900F5F1Q28730963-D638A688-F888-4A44-A9F7-AA15CAC1AC5DQ30009590-BFCAE999-ECDB-4C82-AEE5-682C869D1CD8Q30585855-17651827-F896-47EB-8888-3D2AB067AD57Q33329537-D14F554E-0840-4651-AF76-9C77701D5798Q33491056-900C6BF1-F0D4-458D-9B8E-9D7F46CBF2D3Q33565654-22134212-0F57-4E71-9B8E-A2CD888786D7Q33674271-25212101-0537-4F97-B804-9100E87C9084Q33680841-82998F00-F382-4F9A-AC1E-ECB57C0A940EQ33782512-2DA276CA-BF8F-4A2E-94FB-A4CFCCB92AC1Q33788423-1DFF03F8-067C-40C8-8714-63C39D92A165Q33865593-558DA5AE-E6F3-4E72-BACD-108037A3F932Q33875973-D0D02107-AFA8-457D-A98B-F5684823B525Q33880811-0C609C19-078B-46F2-AE48-01B5DD785751Q34014510-806DC679-E7A0-48AF-B82F-849CFADD655BQ34520959-E1F281BB-7C3D-4230-AE93-97B496549216Q34523555-2854AE2E-E5DD-4B5D-A583-0A6911E529E0Q34659613-AB979B61-EC70-412C-A0FC-DE0E9C376D0BQ35026302-183ADCBA-0E0B-452F-832D-386A2998BACBQ35071512-9049AE49-D4A2-43C5-A1AB-2D4D5FC70F03Q35215366-7D33906C-C684-48D5-A048-74AB58AAF24EQ35569905-9B0CAEF7-0442-4CA3-B64D-CC9D1C461978Q35597021-1B699114-FDCC-41AE-B7F1-6E68D58656B1Q35760360-BE5284AD-232C-48A9-BDEF-A689202F61F7Q35801739-1BA3F497-E817-45C3-97E5-4655EAD953B5Q35813480-87AB125A-F519-431C-9B16-8E5D4116B9BCQ35948456-9DB084AE-9BBA-4424-9FDC-1F9C43A1666D
P2860
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@ast
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@en
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@nl
type
label
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@ast
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@en
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@nl
prefLabel
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@ast
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@en
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@nl
P2093
P50
P1476
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
@en
P2093
Benny Geypens
Liesbeth Lemmens
Maja Noman
Peter Suenaert
Veerle Bulteel
P304
P356
10.1111/J.1572-0241.2002.05914.X
P407
P577
2002-08-01T00:00:00Z